Italian Society of Invasive Cardiology Report issue

Academic/Hospital Phase 4

Organization Overview

First Clinical Trial
2012
NCT01477775
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2012

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 4 Trials (3)

clopidogrel (plavix) (2 trials)

prasugrel (effient) (2 trials)

ticagrelor (brilinta) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Acute Coronary Syndrome (Phase 4)

Arteriosclerosis (Phase 4)

Cardiovascular Diseases (Phase 4)

Coronary Artery Disease (Phase 4)

Ischemia (Phase 4)

Myocardial Ischemia (Phase 4)

Syndrome (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 2
  • # of Trial APIs: 3